Monsaic vs. Stock Screeners: Filtering Candidates vs. Understanding the Case

The short answer

Monsaic wrote this comparison, and you should weigh that as you read it. We have tried to make it genuinely useful even to a reader who finishes it and decides a screener is all they need — because for some investors, that is the honest conclusion.

The distinction is between two jobs. A screener answers a filtering question: “which stocks in the market match these criteria?” It takes a universe of thousands and returns a list. A research report answers an understanding question: “is this one stock worth owning?” It takes a single ticker and returns a thesis — the business, the valuation, the risks, and the conditions that would prove the thesis wrong. Monsaic does the second job. It does not screen the market, and a screener does not build the case. Filtering candidates versus understanding the case: neither tool substitutes for the other.

Where screeners are genuinely useful

The honest starting point is that screeners do their job well, fast, and often for free.

• Systematic idea generation across the whole market. A screener looks at every listed stock at once — something no analyst, human or AI, does. If you want every company under 15x earnings with rising revenue and net cash, a screener finds all of them in seconds. No other tool class does this.
• Factor and metric filters you fully control. The criteria are yours: valuation ratios, growth rates, margins, debt levels, dividend yields, market cap. The screen does exactly what you told it to, with no interpretation layered on top.
• Speed and repeatability. The same screen run every Monday returns comparable results every Monday. That consistency is exactly what a systematic process needs, and it costs seconds.
• Low or zero cost. Capable screeners are free or bundled with brokerage accounts. As a way to survey the entire market, the price is effectively nothing.

For a systematic investor with a defined factor process — someone who buys a screened basket on rules and rebalances on rules — a screener may be most of what they need. That is a real, defensible workflow, and this page will not talk you out of it.

What passing a screen means — and what it doesn’t

A screen result is a fact about metrics, not a thesis. “This stock trades under 10x earnings” is true the moment the screen runs. What it cannot tell you is why — and in investing, the why is usually the whole question.

The canonical failure is the value trap: a stock that looks cheap on the numbers because the business is deteriorating, so the cheapness is real but the bargain is not. A screen for low price-to-earnings ratios surfaces the genuinely mispriced company and the melting ice cube side by side, with equal confidence, because the filter only sees the ratio. The screen is not wrong — both stocks really are cheap on P/E — but “cheap” was never the investment question. The question is whether the market is missing something or you are, and no combination of metric filters can answer it.

The same logic applies to every screen. “High revenue growth” cannot distinguish durable growth from an acquisition spree or a one-time spike. “Low debt” cannot see off-balance-sheet obligations or a pending dilution. Passing a screen means the historical numbers matched your criteria on the day the data was current. It does not mean anyone — or anything — has looked at the company.

Where screeners stop

These are structural properties of the tool class, not flaws of any particular product. A filter is not a smaller analyst; it is a different kind of tool, and there are things it does not produce by design:

• No narrative. A screen returns rows of metrics. It does not explain what the company does, how it makes money, or what has to go right for the numbers to hold.
• No sources beyond the metrics. The screen’s data comes from standardized feeds. It does not read filings, earnings calls, or footnotes — the places where the story behind the numbers lives.
• No bull or bear case. A filter has no view. It cannot tell you what the upside looks like if things go well or how bad the downside gets if they don’t.
• No valuation scenarios. A screen shows today’s multiple. It does not model what the stock could be worth under different futures, or how likely each future is.
• No kill criteria. A screen makes no claim, so nothing can prove it wrong. There are no thesis-breakers — the conditions, defined in advance, that would tell you the investment case has failed — because there is no investment case.

That last point is the deepest one. Research is valuable partly because it can be wrong in a checkable way: a thesis commits to claims the future can falsify. A filter never commits to anything, which is precisely why it is so fast — and why its output is a starting point rather than a conclusion.

The missing middle: from screen to decision

Here is the gap this page exists to name. The screener hands you forty names, and the real work begins: reading the filings, listening to the earnings calls, checking the balance sheet, understanding the dilution history, building a valuation, mapping the risks, and deciding what would make you wrong. That work is what stands between a shortlist and a decision — and the screener, by design, does none of it.

Most individual investors handle this middle stage informally: a skim of headlines, a look at the chart, maybe a forum thread. The result is that the rigorous, systematic part of the process (the screen) feeds into the least rigorous part (the gut check). A research report is the packaged form of that middle work — the thesis, sourcing, valuation, and risk assessment — whoever produces it: a brokerage analyst, an independent shop, or an AI stock research platform. Our guide to AI stock research covers how to evaluate that kind of report and verify what it claims, whoever or whatever wrote it.

How Monsaic is different

Monsaic starts where the screener stops: one ticker in, a sourced fifteen-section report out. The report works through the executive summary, fundamentals, balance sheet, catalysts, valuation and scenarios, comparative precedents, risk, technicals, insider and institutional signals, news sentiment, governance, and the forensic sections — narrative versus substance, dilution, and revenue quality. Every report includes:

• Claim-level citations — a source list tracing material claims back to the filing, transcript, or dated report they came from, so the analysis can be checked rather than merely believed.
• Four valuation scenarios — bull, base, bear, and tail, each with a price target, a probability, what must be true, and what breaks it.
• Kill criteria defined before the verdict — the thesis-breakers written down in advance. Monsaic’s example analysis of NVIDIA (NVDA) states them concretely: hyperscaler and AI-cloud capex plans rolling over for two consecutive quarters; gross margin structurally falling below 68% without a clear mix-transition explanation; competitor or customer silicon taking enough share to flatten data center growth. No screen produces a sentence like any of those. (That is an example of report structure, not investment advice.)
• Forensic grades— management & governance, legal/regulatory, dilution, and revenue quality, each graded A+ through F with a written summary, plus a 1–10 narrative-vs-substance score. These are exactly the checks that catch the value trap a screen surfaces as a bargain.
• An overall verdict with a conviction level, an analysis date, and price-as-of context.

The reasoning behind the structure — why the report checks what it checks — is on the methodology page, and pricing covers what a report costs. The limitations are the mirror image of a screener’s strengths: Monsaic analyzes one company at a time rather than the whole market, research can be incomplete or outdated, it depends on the quality of its sources, and it is educational analysis, not personalized advice.

When to use each

Use a screener when you are generating candidates: surveying the market, applying a factor process, narrowing thousands of stocks to a list worth your attention. It is the right tool for breadth, and nothing else covers the whole market at any price.

Use a research report when you are evaluating a specific name from that list and need the case: what the business is, what it might be worth under different scenarios, what the risks are, and what would prove the thesis wrong.

The tools are complementary, and many investors reasonably run both — screen for breadth, research for depth. The mistake is asking either to do the other’s job: a screener cannot build a thesis, and a per-ticker research report is the wrong instrument for surveying ten thousand stocks.

FAQ

Screeners end where this begins

A screener hands you a list of candidates; a Monsaic is what happens to a single one of them. Read a covered stock’s excerpt — a verdict, a thesis, and the condition that would break it — and see whether that’s the step missing from your process.

Browse covered stocksSee pricing

Keep reading

• AI stock research, done rigorously — the Monsaic pillar
• The Monsaic methodology
• Monsaic vs. stock summaries and news feeds
• Monsaic vs. traditional equity research
• Generate your first Monsaic